Semaglutide belongs to the GLP-1 receptor agonist class, while tirzepatide is a dual GIP/GLP-1 receptor agonist (incretin co-agonist)
By addressing weight challenges at their hormonal source, this therapy empowers patients to achieve meaningful, long-lasting results
Joe Pazona and co-host Cat Williams discuss GLP-1 agonists, often referred to as miracle weight loss drugs, in a new episode of the Balls Deep podcast
This review study highlights the molecular and clinical evidence suggesting boosting GSH protects against oxidative stress, inflammation, and multiple aspects of age-related decline
Reduced inflammation Obesity is strongly linked to inflammation, and chronic inflammation is linked to longer menstrual cycles and follicular phases
Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D., and Wiegand, H